about
Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulationDiagnostic features and subtyping of thymoma lymph node metastases.Quantitative molecular analysis of sentinel lymph node may be predictive of axillary node status in breast cancer classified by molecular subtypes.Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancerUp-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts.Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapyMolecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma.Usefulness of conventional transbronchial needle aspiration in the diagnosis, staging and molecular characterization of pulmonary neoplasias by thin-prep based cytology: experience of a single oncological instituteCancer stem cells: are they responsible for treatment failure?IL-18 receptor marks functional CD8+ T cells in non-small cell lung cancer.E6AP promotes prostate cancer by reducing p27 expressionThymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: a tissue micro array-based multicenter study.The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme.DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.MicroRNA expression profiling of thymic epithelial tumors.Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis
P50
Q33655180-9EB18E28-4DC7-4B9A-9ABC-DA87223696A3Q33943716-AF26E3B6-46DA-4635-966D-2ED1258BB68DQ34637688-D98E61F7-30A2-4513-9A91-99D83316D598Q36022297-A4DD1C13-E350-4FCC-8739-3A9B939C4F6DQ36053878-9D243470-1932-40FD-B9CC-EEB77FAF355DQ36545796-C218AB75-3330-45A6-A57C-E4A54C9FDF03Q36724092-CA4E13C8-377F-49C5-8774-428B9CB129ADQ37208817-0C58C201-C37F-4F02-B9B7-848CD63D8E9EQ38268164-029B9AED-8F60-4CA1-A9F6-E6E3A52FB99AQ38622786-49384B1A-3728-4378-9508-9AEBCD14A7B7Q42335715-30D54599-FB6D-4DB0-9091-26A459703DDAQ45186671-2A08CEFC-CD4F-4F18-B444-E9DDA360410DQ47861000-166A782E-CA39-4F28-B191-432A6C332987Q48199486-1CD60EFE-C0EF-47D9-AD15-B1FA024C0EB7Q49622674-A4B6084E-2278-4822-ACF3-7859FA7540D4Q53236925-A507182D-1821-411B-AEE7-8C22220469E6Q89348203-521D6D76-BA91-49CF-8025-E7AC8C6C83FC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Enzo Gallo
@ast
Enzo Gallo
@en
Enzo Gallo
@es
Enzo Gallo
@nl
Enzo Gallo
@sl
type
label
Enzo Gallo
@ast
Enzo Gallo
@en
Enzo Gallo
@es
Enzo Gallo
@nl
Enzo Gallo
@sl
prefLabel
Enzo Gallo
@ast
Enzo Gallo
@en
Enzo Gallo
@es
Enzo Gallo
@nl
Enzo Gallo
@sl
P106
P1153
55630275200
P21
P31
P496
0000-0002-4938-4071